Gilyazova, I.,
Timasheva, Ya.,
Karunas, A.,
Kazantseva, A.,
Sufianov, A.,
Mashkin, A.,
Korytina, G.,
Wang, Ya.,
Gareev, I.,
Khusnutdinova, E. (2023) knowledge of mechanisms, risk factors,
genetics and neurologic impairments in COVID-19. In addition, we
Sharipov, R.A.,
Omarov, M.A.,
Mulyukov, A.R.,
Dybova, A.I.,
Vyaseleva, E.T.,
Kayumova, N.B.,
Saitgalina, A. Sh.,
Ententeev, K.R.,
Iagafarov, I.R.,
Kuserbaev, I.V.,
Gubaeva, E.A. (2023) and
genetics. However, the application of the CRISPR/Cas9 technology has some limitations and difficulties
Shnayder, Natalia A.,
Ashhotov, Azamat V.,
Trefilova, Vera V.,
Novitsky, Maxim A.,
Medvedev, German V.,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Kaskaeva, Daria S.,
Chumakova, Galina A.,
Garganeeva, Natalia P.,
Lareva, Natalia V.,
Al-Zamil, Mustafa,
Asadullin, Azat R.,
Nasyrova, Regina F. (2023) engineering);
genetic technologies (gene modifications, microRNA, and molecular inducers of IDD); technologies
Elena, Merkuryeva,
Tatiana, Markova,
Anton, Tyurin,
Diana, Valeeva,
Vladimir, Kenis,
Maria, Sumina,
Igor, Sorokin,
Olga, Shchagina,
Mikhail, Skoblov,
Maria, Nefedova,
Rita, Khusainova,
Ekaterina, Zakharova,
Dadali, Elena,
Kutsev, Sergey (2023) of this variant
will contribute to optimal molecular
genetic diagnostics, which can reduce diagnostic costs
Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) the
genetic basis for SARS-CoV-2 infection susceptibility and severe COVID-19. However, data on the
geneticКлинико-генетическая характеристика муковисцидоза в Республике БашкортостанClinical and
genetic characteristics of cystic fibrosis in the Republic of Bashkortostan